Temple Health is testing a tiny, flexible scaffold aimed at relieving a common problem for emphysema patients: overinflation ...

The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

Select your location to view local American Lung Association events and news near you.

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and the broader label. The company has estimated that among people with COPD who ...

Are you feeling out of breath while talking or climbing stairs These silent symptoms may be the first signs of COPD that one ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

If it weren’t for the Interventional Pulmonology team at Geisinger Medical Center and the endobronchial valve procedure, Terry Loss from New Columbia would have lost his life. Believing his days were ...